Toggle Main Menu Toggle Search

Open Access padlockePrints

Which Patients With Dysfunctional Voiding Respond Well to Sacral Neuromodulation? ICI-RS 2025

Lookup NU author(s): Professor Christopher HardingORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 The Author(s). Neurourology and Urodynamics published by Wiley Periodicals LLC.Aims: Dysfunctional voiding (DV) is characterised by fluctuating or intermittent urinary flow during voiding in neurologically normal individuals. Given the different definitions used and heterogeneous pathophysiologies, outcomes following sacral neuromodulation/sacral nerve stimulation (SNM/SNS) are variably reported. The aim was to identify the areas of research required to be able to accurately predict response to SNM/SNS in adults with DV. Methods: The relevant literature was reviewed by a multidisciplinary panel and the findings were discussed at the ICI-RS meeting held in 2025 in the UK. The outcomes of this discussion are presented. Results: DV has unique diagnostic features, typically requiring pressure-flow studies and uroflowmetry to establish the diagnosis. Further investigations such as electromyography and urethral pressure profilometry help to better understand the pathophysiology. Phenotyping the lower urinary tract dysfunction helps to identify patterns of abnormalities, and it is likely that certain groups show a better response to SNM/SNS than others, such as in Fowler's syndrome. Older age and change in body weight following implantation are associated with a worse outcome, though not specifically in DV. Studies evaluating the impact of neuropsychiatric co-morbidities on SNM/SNS outcomes show mixed results. Central dysregulation of micturition networks possibly contribute to DV and could represent an additional therapeutic target of SNM. Conclusion: Precise phenotyping of individuals with DV integrating clinical, urodynamic, neurophysiological, and neuropsychiatric factors is essential to predict which adults respond best to SNM/SNS. Future research should focus on establishing criteria for patient selection and designing comprehensive prospective interventional studies to assess efficacy and complications.


Publication metadata

Author(s): Panicker JN, Harding C, Hashim H, Hentzen C, Bhatt N, Nambiar A, Schurch B, de Rijk M, Musco S

Publication type: Article

Publication status: Published

Journal: Neurourology and Urodynamics

Year: 2025

Pages: epub ahead of print

Online publication date: 26/11/2025

Acceptance date: 24/10/2025

Date deposited: 15/12/2025

ISSN (print): 0733-2467

ISSN (electronic): 1520-6777

Publisher: John Wiley and Sons Inc

URL: https://doi.org/10.1002/nau.70185

DOI: 10.1002/nau.70185

Data Access Statement: Data sharing is not applicable to this article as no datasets were generated or analysed during the current study

PubMed id: 41293820


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Department of Health NIHR University College London Hospitals Biomedical Research Centres funding scheme

Share